2015 - Present
Seven Bridges is the biomedical data analysis company accelerating breakthroughs in genomics research for cancer, drug development and precision medicine. We democratize genomics by enabling researchers anywhere to process and understand genomic data quickly and efficiently, at any scale. Thousands of researchers in government, biotech, pharmaceutical and academic labs use Seven Bridges, including three of the largest genomics projects in the world: U.S. National Cancer Institute’s Cancer Genomics Cloud pilot, the Million Veteran Program, and Genomics England’s 100,000 Genomes Project. As the NIH’s only commercial Trusted Partner, Seven Bridges authenticates and authorizes access to one of the world’s largest cancer genomics dataset.
Named one of the world's smartest companies by MIT Technology Review, Seven Bridges has offices in Cambridge, Mass., San Francisco, London, Belgrade, and Istanbul.
Led Seven Bridges' participation in the White House's Cancer Moonshot program. Seven Bridges focused on using our software to enable the Blood Profiling Atlas project, designed to accelerate the development and approval of simple, accurate, and reliable blood tests for cancer diagnosis and precision treatment.